Fineline Cube

Follow:
14422 Articles
SCG Cell Therapy's SCG142 Receives NMPA Approval for HPV-Related Solid Tumor Clinical Trial
CompanyDrug

SCG Cell Therapy’s SCG142 Receives NMPA Approval for HPV-Related Solid Tumor Clinical Trial

Huadong Medicine's HDM1005 Receives NMPA Approval for MAFLD/MASH Clinical Trial
CompanyDrug

Huadong Medicine’s HDM1005 Receives NMPA Approval for MAFLD/MASH Clinical Trial

Cygenta Partners with IZVARINO Pharma for Comprehensive CDMO Services
CompanyDeals

Cygenta Partners with IZVARINO Pharma for Comprehensive CDMO Services

Pfizer Collaborates with Atavistik Bio to Discover Allosteric Therapeutics
CompanyDeals

Pfizer Collaborates with Atavistik Bio to Discover Allosteric Therapeutics

NMPA Grants Conditional Approval for China's First MSCs Therapy for aGVHD
CompanyDrug

NMPA Grants Conditional Approval for China’s First MSCs Therapy for aGVHD

Genesis MedTech's iReach Omnia Receives NMPA Approval for Rectal Cancer Surgery
CompanyMedical Device

Genesis MedTech’s iReach Omnia Receives NMPA Approval for Rectal Cancer Surgery

Eli Lilly & Co. Launches Mounjaro (Tirzepatide) in China for Diabetes and Weight Management
CompanyDrug

Eli Lilly & Co. Launches Mounjaro (Tirzepatide) in China for Diabetes and Weight Management

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing
CompanyDeals

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing

Brii Biosciences to Acquire Full Rights to BRII-179 from VBI Vaccines
CompanyDeals

Brii Biosciences to Acquire Full Rights to BRII-179 from VBI Vaccines

Shanghai Pharmaceuticals Halts Development of I001-B, I022, and C012 in the US
CompanyDrug

Shanghai Pharmaceuticals Halts Development of I001-B, I022, and C012 in the US

Astellas Pharma's Vyloy Approved by NMPA for CLDN18.2 Positive Gastric Cancer
CompanyDrug

Astellas Pharma’s Vyloy Approved by NMPA for CLDN18.2 Positive Gastric Cancer

Sichuan Kelun-Biotech's Ketailai Receives NMPA Approval for Nasopharyngeal Carcinoma Treatment
CompanyDrug

Sichuan Kelun-Biotech’s Ketailai Receives NMPA Approval for Nasopharyngeal Carcinoma Treatment